JP2008546842A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546842A5
JP2008546842A5 JP2008519483A JP2008519483A JP2008546842A5 JP 2008546842 A5 JP2008546842 A5 JP 2008546842A5 JP 2008519483 A JP2008519483 A JP 2008519483A JP 2008519483 A JP2008519483 A JP 2008519483A JP 2008546842 A5 JP2008546842 A5 JP 2008546842A5
Authority
JP
Japan
Prior art keywords
cerium oxide
oxide nanoparticles
cell
disease
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008519483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008546842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/024963 external-priority patent/WO2007002662A2/en
Publication of JP2008546842A publication Critical patent/JP2008546842A/ja
Publication of JP2008546842A5 publication Critical patent/JP2008546842A5/ja
Pending legal-status Critical Current

Links

JP2008519483A 2005-06-27 2006-06-27 酸化セリウムナノ粒子の抗炎症性、放射線防護性および寿命促進能 Pending JP2008546842A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69393005P 2005-06-27 2005-06-27
PCT/US2006/024963 WO2007002662A2 (en) 2005-06-27 2006-06-27 Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles

Publications (2)

Publication Number Publication Date
JP2008546842A JP2008546842A (ja) 2008-12-25
JP2008546842A5 true JP2008546842A5 (enExample) 2009-08-13

Family

ID=37595977

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008519483A Pending JP2008546842A (ja) 2005-06-27 2006-06-27 酸化セリウムナノ粒子の抗炎症性、放射線防護性および寿命促進能

Country Status (6)

Country Link
US (2) US20100166821A1 (enExample)
EP (1) EP1904072A4 (enExample)
JP (1) JP2008546842A (enExample)
AU (1) AU2006261764A1 (enExample)
CA (1) CA2613086A1 (enExample)
WO (1) WO2007002662A2 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857178B2 (en) * 2005-06-27 2020-12-08 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for treatment and prevention of Alzheimer's disease, Parkinson's disease, and disorders associated with free radical production and/or mitochondrial dysfunction
US9649337B2 (en) 2005-06-27 2017-05-16 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for the treatment and prevention of stroke and cardiovascular disease
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
WO2008018932A2 (en) 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
US8333993B1 (en) * 2006-12-29 2012-12-18 University Of Central Florida Research Foundation, Inc. Synthesis of polymer coated ceria nanoparticles for biomedical applications
US20080166412A1 (en) 2007-01-02 2008-07-10 Kiminobu Sugaya Methods and materials for stimulating proliferation of stem cell
KR100876361B1 (ko) * 2007-05-11 2008-12-29 주식회사 태웅이엘에스 슬리밍용 조성물
US9119391B1 (en) * 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
EP2288258A4 (en) * 2008-04-25 2012-10-31 Univ Oklahoma INHIBITION OF NEOVASCULARIZATION BY CERIUM OXIDE NANOPARTICLES
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
US20160074434A1 (en) * 2010-07-22 2016-03-17 University Of Central Florida Research Foundation, Inc. Application Device for Inducing Cytotoxicity to Tumor Cells Via Coated Cerium Oxide Nanoparticles
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
DK201000969A (en) * 2010-10-25 2012-04-26 Entomopharm Aps Insect-based ex vivo model for testing blood-brainbarrier penetration and method for exposinginsect brain to nanoparticles
US11116792B1 (en) 2010-12-22 2021-09-14 Biocurity Holdings, Inc. Cerium oxide nanoparticle formulation for use in skin radioprotection and associated methods
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
CA2869554A1 (en) * 2012-04-04 2013-10-10 Duke University Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury
WO2013158744A2 (en) 2012-04-17 2013-10-24 Cerion Enterprises, Llc Nanoparticles of cerium and amino acids
US9446070B2 (en) 2012-06-13 2016-09-20 Cerion, Llc Nanoceria with citric acid additive
JP6174692B2 (ja) 2012-06-13 2017-08-02 セリオン エンタープライジズ リミテッド ライアビリティ カンパニー 酸化ストレスの処置のためのナノセリア
WO2014008503A1 (en) * 2012-07-06 2014-01-09 University Of Central Florida Research Foundation, Inc. Methods of using ceo2 and tio2 nanoparticles in modulation of the immune system
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
WO2014134286A2 (en) * 2013-03-01 2014-09-04 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles accelerate the decay of peroxynitrite (onoo-)
US9549950B2 (en) 2013-04-25 2017-01-24 Cerion, Llc Chelated nanoceria for the treatment of oxidative stress
US9623110B2 (en) 2013-08-09 2017-04-18 Cerion, Llc Nanoparticles of a metal and a nucleobase
WO2015058037A1 (en) 2013-10-17 2015-04-23 Cerion, Llc Malic acid stabilized nanoceria particles
US9669055B1 (en) * 2014-04-11 2017-06-06 Marshall University Research Corporation Methods for treating sepsis
CN103983777A (zh) * 2014-05-07 2014-08-13 大连理工大学 一种基于纳米二氧化铈仿生氧化酶的微囊藻毒素比色检测方法
AU2015289504B2 (en) * 2014-07-17 2020-12-17 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
JP2018508568A (ja) 2015-01-20 2018-03-29 セリオン,リミティド ライアビリティ カンパニー カタラーゼ様活性を有するeddsでキレート化されたナノセリア
JP2016204368A (ja) * 2015-04-14 2016-12-08 株式会社Applause 酸化セリウム微粒子を含有する組成物
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
US11833172B2 (en) 2015-11-25 2023-12-05 The Regents Of The University Of Colorado Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration
KR101696903B1 (ko) 2016-04-20 2017-01-17 서울대학교병원 세리아 나노복합체를 포함하는 비외상성 두개내 출혈 치료용 약학적 조성물
CN107789627B (zh) * 2017-09-26 2021-05-07 西北农林科技大学 可降解聚多巴胺包封的靶向双刺激响应性多功能二氧化铈纳米载药体系
KR102102535B1 (ko) * 2018-07-26 2020-04-21 서울대학교산학협력단 방사선 보호 나노입자
EP3867407A4 (en) * 2018-07-26 2022-09-14 Edward Via College of Osteopathic Medicine BLOOD PRESERVATION COMPOSITIONS, DEVICES, AND USES THEREOF
JP7328480B2 (ja) * 2018-09-14 2023-08-17 株式会社applause Pharma チロシン-チロシナーゼ反応阻害剤
WO2020069292A1 (en) * 2018-09-28 2020-04-02 The Regents Of The University Of Colorado, A Body Corporate Methods for preventing and treating pulmonary inflammation and fibrosis
CN112516294B (zh) * 2020-12-22 2023-04-07 浙江大学 一种氧化铈纳米稳定剂在制备预防过敏性疾病药物中的应用及预防过敏性疾病的药物组合物
US12480009B2 (en) 2021-07-30 2025-11-25 Xheme Inc. Nanoporous cerium oxide nanoparticle macro-structure
WO2023060246A1 (en) * 2021-10-08 2023-04-13 Xheme Inc. Blood preservation compositions, devices and uses thereof utilizing: a. zirconium dioxide nanoparticles or nanoporous zirconium dioxide nanoparticle macrostructures; and b. nanoporous cerium oxide nanoparticle macrostructures
CN116942695A (zh) * 2022-04-20 2023-10-27 中国科学院深圳先进技术研究院 二氧化铈作为炎症小体抑制剂在疾病治疗中的应用
CN116270729A (zh) * 2022-11-09 2023-06-23 西安交通大学医学院第一附属医院 多孔纳米棒状氧化铈在制备治疗特应性皮炎的药物中的应用
AU2024285952A1 (en) * 2023-06-09 2025-12-04 Xheme Inc. Bioreactors providing cerium oxide and zirconium dioxide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG38903A1 (en) * 1995-03-16 1997-04-17 Gen Electric Acrylic coatings containing inorganic UV screen
JP2746861B2 (ja) * 1995-11-20 1998-05-06 三井金属鉱業株式会社 酸化セリウム超微粒子の製造方法
US6413489B1 (en) * 1997-04-15 2002-07-02 Massachusetts Institute Of Technology Synthesis of nanometer-sized particles by reverse micelle mediated techniques
GB0126663D0 (en) * 2001-11-06 2002-01-02 Oxonica Ltd Cerium oxide nanoparticles
US6669823B1 (en) * 2002-06-17 2003-12-30 Nanophase Technologies Corporation Process for preparing nanostructured materials of controlled surface chemistry
US7534453B1 (en) * 2002-09-05 2009-05-19 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles and use in enhancing cell survivability
JP4054869B2 (ja) * 2002-12-25 2008-03-05 独立行政法人産業技術総合研究所 抵抗型酸素センサの酸素分圧検出部分の製造方法
DE10337199A1 (de) * 2003-08-13 2005-03-10 Degussa Ceroxidpulver
CA2610296C (en) * 2005-04-29 2016-06-14 University Of Central Florida Research Foundation, Inc. Inhibition of reactive oxygen species and protection of mammalian cells

Similar Documents

Publication Publication Date Title
JP2008546842A5 (enExample)
Mekbib et al. Proactive motor functional recovery following immersive virtual reality–based limb mirroring therapy in patients with subacute stroke
Prasko et al. The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study
Wang et al. Nanoparticles isolated from porcine bone soup ameliorated dextran sulfate sodium-induced colitis and regulated gut microbiota in mice
JP2020513032A5 (enExample)
WO2023237124A1 (zh) 一种藏红花素混悬剂及其在制备快速抗抑郁药物中的应用
Sun et al. Two-sided cellular and physiological effects of zinc oxide nanoparticles (nZnO): a critical review
CN103946019B (zh) 铁-纤维组合物、其制备和用途
JP6985652B2 (ja) 磁性材料、該磁性材料を用いためがね、レンズおよびめがね用アクセサリー
CN104758954A (zh) 一种基于金属离子诱导多肽自组装的双功能纳米复合球及其制备方法
KR101820082B1 (ko) 지방간을 갖는 골다공증 동물 모델의 생산 방법
Zheng et al. Cerebellar continuous theta burst stimulation for aphasia rehabilitation: study protocol for a randomized controlled trial
Malicka et al. Physical activity, life satisfaction and adjustment to illness in women after treatment of breast cancer
Ovissipour et al. Impact of engineered nanoparticles on aquatic organisms
CN204496126U (zh) 一种防辐射保健眼镜
Nganvongpanit et al. Side effects in 412 dogs from swimming in a chlorinated swimming pool
CN202842539U (zh) 一种具有掺杂了银离子改性粉煤灰层的抗菌按摩鞋垫
Syeda et al. Effects of Transcranial Magnetic Stimulation on Parkinsonian Motor Neurons
Tsoukalas et al. EP10. 01-018 Thromboprophylaxis for Lung Cancer Patients: Results From ACT4CAT Trial
Jiang et al. A potential mechanism underlying the effects of acupuncture on insulin resistance
Cart Probiotic Potential for Heavy Metal Detoxification
CN107019289A (zh) 鞋垫及其制作工艺
Yoshimura et al. Proteomic analysis of macrophages temporarily stimulated with albumin, oxidized or reduced galectin-1
Cucca HIGH ORDER VISUOPERCEPTUAL IMPAIRMENTS UNDERSCORE SPECIFIC PERCEPTUAL PERFORMANCES ON ILLUSORY FIGURES IN PATIENTS WITH PARKINSON’S DISEASE: IMPLICATIONS FOR VISUAL HALLUCINATIONS
Pahwa et al. Study design and rationale for an international study of DBS for movement disorders